top of page
  • Regulatory House

Draft reflection paper on the use of AI: Public consultation opened

The paper opens a dialogue with developers, academics, and other regulators on the topic of how AI /ML can support the medicinal product lifecycle.

Stakeholders are invited to comment on this draft by 31 December 2023.

1 view0 comments

Recent Posts

See All

Which products cannot be registered?

SÚKL has published several types of products on its website for which it is no longer possible to apply for registration as a medicinal product, as they do not meet the definition under Section 2 of A


bottom of page